Justin Engel
justeng95.bsky.social
Justin Engel
@justeng95.bsky.social
PhD Candidate in the Ly lab at UT Southwestern // Genomic instability in cancer // views are my own
Reposted by Justin Engel
Cytarabine has been the mainstay for AML treatment for over 50 years. This chemotherapy can lead to problems with movement and balance. Here we explain this neurotoxic side-effect. www.nature.com/articles/s41... Work led by Jia-Cheng Liu, Donpeng Wang and Elsa Callen and terrific collaborators!
Mechanism of cytarabine-induced neurotoxicity - Nature
Certain antimetabolites used to treat cancer are more neurotoxic than others, and it is now shown that this is due to their greater tendency to generate DNA double-stranded breaks, whereas less n...
www.nature.com
June 25, 2025 at 3:59 PM
Reposted by Justin Engel
Super cool new preprint: FANCD2:FANCI is a sensor of open chromatin, independent of DNA damage, but further increased at double strand breaks.
www.biorxiv.org/content/10.1...
The FANCD2-FANCI heterodimer coordinates chromatin openness and cell cycle progression throughout DNA double-strand break repair
The FANCD2-FANCI heterodimer contributes to DNA repair at interstrand crosslinks and sites of replication stress. This complex has been physically and mechanistically linked to double-strand break (DSB) repair, but its role in that process remains undefined. Here we show that the FANCD2-FANCI heterodimer dynamically interacts with open chromatin regions, including transient, DSB-induced open chromatin, where it can be stabilized by co-activation by the DNA repair kinase ATM and the Fanconi anemia core ubiquitin ligase. The loaded FANCD2-FANCI heterodimer stabilizes open chromatin and promotes resection and loading of RPA through increased association of BRCA1 and BLM. Chromatin-loaded FANCD2-FANCI has a second distinct function promoting a G2 arrest that is dependent on the ATR-CHK1-WEE1 axis. Our results support a two-step genome surveillance model in which FANCD2-FANCI monitors open chromatin sites and is stably loaded to coordinate DNA repair activities in response to signaling from a DNA repair kinase. ### Competing Interest Statement The authors have declared no competing interest.
www.biorxiv.org
April 24, 2025 at 4:24 AM
Reposted by Justin Engel
FANCX=FAAP100, new Fanconi Anemia gene
Two new papers identify 3 families with FAAP100 homozygous mutations leading to severe developmental and hematologic abnormalities leading to death in utero or in early life.
www.jci.org/articles/vie...
www.jci.org/articles/vie...
JCI - Genetic inactivation of FAAP100 causes Fanconi anemia due to disruption of the monoubiquitin ligase core complex
www.jci.org
April 25, 2025 at 4:56 PM
Reposted by Justin Engel
New preprint from the lab led by Yanyang Chen identifies BAF as a key regulator of TREX1 activity at micronuclei.
ER-tethering directs TREX1 penetration of a BAF-dependent barrier at micronuclei https://www.biorxiv.org/content/10.1101/2025.04.14.648782v1
April 16, 2025 at 11:39 AM
Reposted by Justin Engel
We have two #postdoc positions open to join my team at @ebi.embl.org in beautiful Cambridge!
We are a mission-driven, highly collaborative and dynamic team located at the Wellcome Genome Campus, one of the most exciting hubs in the world focused on biomedical research 👇
Postdoctoral Fellow
Your group The Cortes-Ciriano group studies the mutational processes and mechanisms of genome instability underpinning tumourigenesis, immune escape, and drug response through the analysis of high-thr...
embl.wd103.myworkdayjobs.com
April 4, 2025 at 11:37 AM
Reposted by Justin Engel
Excited to share our new pre-print. Direct, ensemble FRET assays developed by our lab reveal that assembly of Rad51 filaments at stalled replication sites via RPA/Rad51 exchange causes complete & irreversible PCNA unloading. Big implications for interplay between human DNA damage tolerance pathways
www.biorxiv.org
April 1, 2025 at 5:58 PM
Reposted by Justin Engel
“You don’t take these jobs that pay worse and have insane hours and are really stressful unless you care about helping others and taking our love for science and translating that into something that can improve people’s lives.”
March 16, 2025 at 11:12 AM
Reposted by Justin Engel
We show transcriptomic buffering of tumour suppressor loss via syn. lethal genes is not anecdotal but a cancer hallmark. Buffering also seen in BRCAness, predicts penetrant syn leth effects and outcome. @icr.ac.uk @cancerresearchuk.org @breastcancernow.bsky.social www.nature.com/articles/s41...
The transcriptomic architecture of common cancers reflects synthetic lethal interactions - Nature Genetics
Tumor cells upregulate compensatory buffering genes following tumor suppressor loss. These genes may represent new synthetic lethal partners that could be harnessed therapeutically.
www.nature.com
March 3, 2025 at 11:16 AM
Reposted by Justin Engel
Please check out our preprint where we find that mitotic transcription helps ensure ecDNA inheritance through chromosomal tethering:

www.biorxiv.org/content/10.1...
www.biorxiv.org
February 17, 2025 at 11:04 AM
Reposted by Justin Engel
This is a room where we turn very modest salaries and budgets (and lots of coffee) into new knowledge, life-saving innovations, and technology that feeds business growth.

It's literally the loom that spins hay into gold but these numpties are suddenly worried about the cost of hay.
February 10, 2025 at 11:59 PM
This one looks exactly like two recently divided daughter cells with an interphase bridge!
February 3, 2025 at 3:25 PM
Reposted by Justin Engel
“What is seven days?” Is the apparent Jeopardy answer to the question of how long it would take to dismantle what made America great and its standing in the world.
January 28, 2025 at 8:49 PM
Reposted by Justin Engel
Congratulations to Jenna Whalen on her Nature Cancer paper out today-a distinct take on nicks and their toxicity! rdcu.be/d60Td
Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability
Nature Cancer - Whalen et al. report that increased DNA end resection in BRCA-deficient, PARP inhibitor-resistant cancers leads to increased sensitivity to DNA nicks, limiting tumor formation in...
rdcu.be
January 21, 2025 at 5:26 PM
Reposted by Justin Engel
Super excited to share our most recent pre-print, lead by K99 fellow @heyzajr.bsky.social, who will be starting his own lab at Wayne State University in February!

The question is how are DNA breaks held together during HR?? 1/n

www.biorxiv.org/content/10.1...
The PST repeat region of MDC1 is a tunable multivalent chromatin tethering domain
DNA double strand breaks (DSBs) are widely considered the most cytotoxic DNA lesions occurring in cells because they physically disrupt the connectivity of the DNA double helix. Homologous recombinati...
www.biorxiv.org
January 13, 2025 at 2:26 PM
Reposted by Justin Engel
#1 Happy to share our last work published in @NatureCellBio about a new cell cycle checkpoint that senses nuclear shape & mechanics to guarantee genome integrity
www.nature.com/articles/s41.... Great work from @sol-herve.bsky.social & Andrea Scelfo in close collaboration with @katemiro.bsky.social
Chromosome mis-segregation triggers cell cycle arrest through a mechanosensitive nuclear envelope checkpoint - Nature Cell Biology
Hervé, Scelfo et al. show that chromosome mis-segregation induces mTORC2- and ATR-mediated p53 activation through a mechanosensitive checkpoint at the nuclear envelope triggered by altered heterochrom...
www.nature.com
January 8, 2025 at 12:11 PM
Reposted by Justin Engel
Happy holidays from the Ly Lab! Wishing all of your papers and proposals are met with fair and favorable reviews in 2025!
December 20, 2024 at 12:16 PM
Reposted by Justin Engel
🧪1/ 🚨New paper on ecDNAs from our lab!
We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in! Let’s dive in! 🧵👇
www.nature.com/articles/s41...
Engineered extrachromosomal oncogene amplifications promote tumorigenesis - Nature
Large extrachromosomal DNAs are engineered using a CRISPR- and Cre–loxP-based approach and shown to drive cancer in mouse models, with potential applications in determining the role of oncogene a...
www.nature.com
December 18, 2024 at 4:54 PM
Reposted by Justin Engel
Delighted to publish my new molecular animation:

DNA Break Repair by Homologous Recombination

youtu.be/Xe-83tBcxhs
DNA Break Repair by Homologous Recombination (2024) Drew Berry wehi.tv
YouTube video by WEHImovies
youtu.be
December 4, 2024 at 12:07 AM
Reposted by Justin Engel
Review on synthetic lethal strategies in oncology, with a small contribution from yours truly.

www.nature.com/articles/s41...
Synthetic lethal strategies for the development of cancer therapeutics - Nature Reviews Clinical Oncology
The experience with PARP inhibitors provides evidence of the clinical utility of synthetic lethality, whereby the simultaneous presence of two specific alterations is required for antitumour activity....
www.nature.com
December 4, 2024 at 2:26 PM
Reposted by Justin Engel
Mcm10 — an important replication and elongation factor, counteracts repeat instability and ensures survival of yeast cells containing large homopurine homopyrimidine repeats, such as GAA associated with Friedreich’s Ataxia and AAGGG associated with CANVAS. 🧬 @natureportfolio.bsky.social
Stabilization of expandable DNA repeats by the replication factor Mcm10 promotes cell viability
Nature Communications - DNA repeats can lengthen or shorten during their replication, which may lead to a human disease. Here, the authors discovered that an essential replication protein, Mcm10,...
rdcu.be
December 4, 2024 at 12:30 PM
Reposted by Justin Engel
TTF2 promotes replisome eviction from stalled forks in mitosis https://www.biorxiv.org/content/10.1101/2024.11.30.626186v1
TTF2 promotes replisome eviction from stalled forks in mitosis https://www.biorxiv.org/content/10.1101/2024.11.30.626186v1
When cells enter mitosis with under-replicated DNA, sister chromosome segregation is compromised, wh
www.biorxiv.org
December 1, 2024 at 5:46 AM
The goal is not to have a zero risk project; those are generally not worth working on. People with a good relationship with risk are definitely not avoiding it. They are super honest about it and they basically make it their goal to slowly chip away at it.
nightscience.buzzsprout.com/1744020/epis...
66 | Michael Fischbach and the scientific decision tree - Night Science
In this episode, Stanford professor Michael Fischbach discusses insights from his course on how to choose meaningful research problems. Highlights include:- Invest time in problem selection: Spend mor...
nightscience.buzzsprout.com
November 25, 2024 at 6:40 PM
Reposted by Justin Engel
From @seedgeorge.bsky.social Johann De Bono and colleagues (us !). In BRCA2m CRPC, reversion mutations emerge in 79% by end of olaparib treatment. Reversions associate with PFS and OS. Rare subclones without BRCA2-loss also emerge authors.elsevier.com/sd/article/S...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
authors.elsevier.com
November 21, 2024 at 4:31 PM
Reposted by Justin Engel
Thank you @gabriellebrewer.bsky.social for highlighting our work in Nature Reviews Cancer, led by grad student @justeng95.bsky.social.

Check out the original paper in Cell here:
www.cell.com/cell/fulltex...

Here's a summary thread from "the other site": x.com/PeterLyLab/s...
November 21, 2024 at 4:23 PM